JP2024546107A5 - - Google Patents

Info

Publication number
JP2024546107A5
JP2024546107A5 JP2024534260A JP2024534260A JP2024546107A5 JP 2024546107 A5 JP2024546107 A5 JP 2024546107A5 JP 2024534260 A JP2024534260 A JP 2024534260A JP 2024534260 A JP2024534260 A JP 2024534260A JP 2024546107 A5 JP2024546107 A5 JP 2024546107A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
alkyl
cyano
occurrence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534260A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546107A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081236 external-priority patent/WO2023108103A1/en
Publication of JP2024546107A publication Critical patent/JP2024546107A/ja
Publication of JP2024546107A5 publication Critical patent/JP2024546107A5/ja
Pending legal-status Critical Current

Links

JP2024534260A 2021-12-09 2022-12-09 Rafキナーゼ阻害剤及びその使用方法 Pending JP2024546107A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163287866P 2021-12-09 2021-12-09
US63/287,866 2021-12-09
US202263393440P 2022-07-29 2022-07-29
US63/393,440 2022-07-29
PCT/US2022/081236 WO2023108103A1 (en) 2021-12-09 2022-12-09 Raf kinase inhibitors and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024546107A JP2024546107A (ja) 2024-12-17
JP2024546107A5 true JP2024546107A5 (cg-RX-API-DMAC7.html) 2025-12-16

Family

ID=85018968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534260A Pending JP2024546107A (ja) 2021-12-09 2022-12-09 Rafキナーゼ阻害剤及びその使用方法

Country Status (8)

Country Link
US (1) US20230357179A1 (cg-RX-API-DMAC7.html)
EP (1) EP4444430A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024546107A (cg-RX-API-DMAC7.html)
CN (1) CN119585242A (cg-RX-API-DMAC7.html)
AU (1) AU2022405115A1 (cg-RX-API-DMAC7.html)
CA (1) CA3240192A1 (cg-RX-API-DMAC7.html)
TW (1) TW202342442A (cg-RX-API-DMAC7.html)
WO (1) WO2023108103A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102708177B1 (ko) 2018-01-31 2024-09-23 데시페라 파마슈티칼스, 엘엘씨. 위장관 기질 종양의 치료를 위한 병용 요법
US20250361234A1 (en) * 2022-06-06 2025-11-27 Nico Therapeutics, Inc. Compounds, compositions, and methods
JP2026522350A (ja) * 2023-06-13 2026-07-07 デシフェラ・ファーマシューティカルズ,エルエルシー 二重raf阻害剤及びチューブリン阻害剤及びその使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1505064A1 (en) * 2003-08-05 2005-02-09 Bayer HealthCare AG 2-Aminopyrimidine derivatives
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
US8906944B2 (en) * 2009-09-03 2014-12-09 Allergan, Inc. Compounds as tyrosine kinase modulators
AR090151A1 (es) 2012-03-07 2014-10-22 Lilly Co Eli Compuestos inhibidores de raf
JP6636014B2 (ja) * 2014-09-12 2020-01-29 ノバルティス アーゲー Rafキナーゼ阻害剤としての化合物および組成物
JP2022525885A (ja) * 2019-03-22 2022-05-20 キネート バイオファーマ インク. Rafキナーゼの阻害剤
AU2020371727B2 (en) * 2019-10-24 2026-01-22 Pierre Fabre Medicament Inhibitors of RAF kinases
WO2022060996A1 (en) * 2020-09-18 2022-03-24 Kinnate Biopharma Inc. Inhibitors of raf kinases

Similar Documents

Publication Publication Date Title
CN115734966A (zh) 杂环化合物及其用途
DK2197878T3 (en) FORMATIONS OF kinase inhibitors AND USE THEREOF FOR THE TREATMENT OF CANCER AND OTHER DISEASES RELATED TO kinases
JP2008528467A5 (cg-RX-API-DMAC7.html)
JP2015517574A5 (cg-RX-API-DMAC7.html)
JP2007534695A5 (cg-RX-API-DMAC7.html)
JP2024546478A5 (cg-RX-API-DMAC7.html)
JP2010265302A5 (cg-RX-API-DMAC7.html)
CN114430739A (zh) Egfr抑制剂、组合物及其制备方法
JP2021519786A5 (cg-RX-API-DMAC7.html)
WO2004112793B1 (en) Guanidino-substituted quinazolinone compounds as mc4-r agonists
RU2010106878A (ru) Комбинация антимитотического агента и ингибитора аврора киназы как средство для лечения рака
JP2021512059A5 (cg-RX-API-DMAC7.html)
JP2015526519A5 (cg-RX-API-DMAC7.html)
RU2005136368A (ru) Производные пиперазина и их применение для лечения неврологических и психиатрических заболеваний
JP2022548250A5 (cg-RX-API-DMAC7.html)
JP2010501003A5 (cg-RX-API-DMAC7.html)
JP2011511095A5 (cg-RX-API-DMAC7.html)
RU2014115847A (ru) Пирролопиримидиновые соединения для лечения злокачественной опухоли
EP1122242A1 (en) Cyanophenyl derivatives
KR20130129244A (ko) 치환된 6,6-융합된 질소 헤테로환형 화합물 및 이의 용도
JP2023533203A5 (cg-RX-API-DMAC7.html)
JP2013522292A5 (cg-RX-API-DMAC7.html)
CN111315744B (zh) 杂芳基并四氢吡啶类化合物、其制备方法、药物组合物及应用
JP2023531709A5 (cg-RX-API-DMAC7.html)
JP2010520893A5 (cg-RX-API-DMAC7.html)